Related Experiment Video
Updated: Aug 14, 2025
14:39
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
32.0K
Propranolol Therapy for Congenital Chylothorax.
Roxane Handal-Orefice1,2, Devin Midura3,2, June K Wu3
1Departments of Obstetrics and Gynecology.
Pediatrics
|January 18, 2023
Summary
Propranolol shows promise for treating severe congenital chylothorax, a rare condition. This study found propranolol effective in resolving fetal chylothorax, with no significant complications.
Area of Science:
- Neonatal Medicine
- Pediatric Cardiology
- Fetal Medicine
Background:
- Congenital chylothorax is a rare and severe condition lacking established medical treatments.
- Previous studies suggested propranolol may help with lymphatic malformations and secondary chylothorax.
Purpose of the Study:
- To evaluate the efficacy of propranolol in treating severe congenital chylothorax.
- To assess outcomes of prenatal and postnatal propranolol therapy in neonates.
Main Methods:
- Retrospective review of neonates with severe congenital chylothorax diagnosed prenatally (2015-2019).
- Analysis of cases receiving prenatal or postnatal propranolol therapy.
- Inclusion criteria: severe fetal chylothorax without major genetic, infectious, or cardiac anomalies.
Main Results:
- Prenatal propranolol led to complete resolution of chylothorax before birth in 2 cases.
- Postnatal propranolol stabilized and improved pleural effusions in 2 neonates with refractory chylothorax.
- No significant maternal or neonatal complications were observed with propranolol use.
Conclusions:
- Propranolol may be an effective treatment for severe congenital chylothorax.
- Both prenatal and postnatal administration of propranolol demonstrated positive outcomes.
- Further research is warranted to confirm propranolol's role in managing fetal chylothorax.
Related Concept Videos
01:26Mitral Stenosis III: Medical Management
16
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
16
01:27Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
921
β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in...
921
01:25Mitral Regurgitation III: Medical Management
24
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
24
01:28Mitral Regurgitation IV: Nursing Management
68
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
68
01:27Mitral Stenosis IV: Nursing Management
25
A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
25
01:25Aortic Regurgitation III: Medical Management
32
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
32